A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
复制标题
DOI:
10.1038/s41467-018-05226-0
复制
发表时间:
2018-07-23
影响因子:
16.6
通讯作者:
Mimori K
中科院分区:
文献类型:
--
作者:
Saito T;Niida A;Uchi R;Hirata H;Komatsu H;Sakimura S;Hayashi S;Nambara S;Kuroda Y;Ito S;Eguchi H;Masuda T;Sugimachi K;Tobo T;Nishida H;Daa T;Chiba K;Shiraishi Y;Yoshizato T;Kodama M;Okimoto T;Mizukami K;Ogawa R;Okamoto K;Shuto M;Fukuda K;Matsui Y;Shimamura T;Hasegawa T;Doki Y;Nagayama S;Yamada K;Kato M;Shibata T;Mori M;Aburatani H;Murakami K;Suzuki Y;Ogawa S;Miyano S;Mimori K
Advanced colorectal cancer harbors extensive intratumor heterogeneity shaped by neutral evolution; however, intratumor heterogeneity in colorectal precancerous lesions has been poorly studied. We perform multiregion whole-exome sequencing on ten early colorectal tumors, which contained adenoma and carcinoma in situ. By comparing with sequencing data from advanced colorectal tumors, we show that the early tumors accumulate a higher proportion of subclonal driver mutations than the advanced tumors, which is highlighted by subclonal mutations in KRAS and APC. We also demonstrate that variant allele frequencies of subclonal mutations tend to be higher in early tumors, suggesting that the subclonal mutations are subject to selective sweep in early tumorigenesis while neutral evolution is dominant in advanced ones. This study establishes that the evolutionary principle underlying intratumor heterogeneity shifts from Darwinian to neutral evolution during colorectal tumor progression. Advanced colorectal cancers are characterised by intra-tumour heterogeneity dictated by neutral evolution. Here the authors analyse early colorectal tumours by whole-exome sequencing and find that Darwinian evolution determines the fate of early lesions in colorectal adenoma and carcinoma in situ.
登录
查看更多内容
DOI:
10.1093/annonc/mdu479
发表时间:
2015-01
期刊:
Annals of oncology : official journal of the European Society for Medical Oncology
影响因子:
--
作者:
Favero F;Joshi T;Marquard AM;Birkbak NJ;Krzystanek M;Li Q;Szallasi Z;Eklund AC
通讯作者:
Eklund AC
影响因子:
30.8
作者:
Makohon-Moore AP;Zhang M;Reiter JG;Bozic I;Allen B;Kundu D;Chatterjee K;Wong F;Jiao Y;Kohutek ZA;Hong J;Attiyeh M;Javier B;Wood LD;Hruban RH;Nowak MA;Papadopoulos N;Kinzler KW;Vogelstein B;Iacobuzio-Donahue CA
通讯作者:
Iacobuzio-Donahue CA
影响因子:
17.1
作者:
McGranahan N;Favero F;de Bruin EC;Birkbak NJ;Szallasi Z;Swanton C
通讯作者:
Swanton C
影响因子:
4.7
作者:
Losi, L;Baisse, B;Benhattar, J
通讯作者:
Benhattar, J
影响因子:
24.5
作者:
Carvalho, B.;Postma, C.;Meijer, G. A.
通讯作者:
Meijer, G. A.